{"id":"https://openalex.org/W1998407948","doi":"https://doi.org/10.1111/bjh.12107","title":"Guideline on the management of bleeding in patients on antithrombotic agents","display_name":"Guideline on the management of bleeding in patients on antithrombotic agents","alternate_titles":[],"publication_year":2012,"publication_date":"2012-11-01","ids":{"openalex":"https://openalex.org/W1998407948","doi":"https://doi.org/10.1111/bjh.12107","mag":"1998407948","pmid":"https://pubmed.ncbi.nlm.nih.gov/23116425"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.12107","doi":"https://doi.org/10.1111/bjh.12107","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.12107","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1998407948"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Mike Makris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210102902"]},{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Mike Makris","raw_affiliation_strings":["Department of Cardiovascular Science, University of Sheffield, Sheffield, UK","Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Science, University of Sheffield, Sheffield, UK","institution_ids":["https://openalex.org/I91136226"]},{"raw_affiliation_string":"Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK","institution_ids":["https://openalex.org/I4210102902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111820610","display_name":"Joost J. van Veen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joost J. Van Veen","raw_affiliation_strings":["Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK","institution_ids":["https://openalex.org/I4210102902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070403731","display_name":"Robert Campbell Tait","orcid":"https://orcid.org/0000-0003-4842-6783","observed_orcids":["https://orcid.org/0000-0003-4842-6783"]},"institutions":[{"id":"https://openalex.org/I2800666604","display_name":"Glasgow Royal Infirmary","ror":"https://ror.org/00bjck208","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2800666604"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Campbell R. Tait","raw_affiliation_strings":["Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK","institution_ids":["https://openalex.org/I2800666604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025294145","display_name":"Andrew David Mumford","orcid":"https://orcid.org/0000-0002-5523-511X","observed_orcids":["https://orcid.org/0000-0002-5523-511X"]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew D. Mumford","raw_affiliation_strings":["Bristol Heart Institute, Bristol Royal Infirmary, University of Bristol, Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Heart Institute, Bristol Royal Infirmary, University of Bristol, Bristol, UK","institution_ids":["https://openalex.org/I2802901496","https://openalex.org/I36234482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039321983","display_name":"Michael Laffan","orcid":"https://orcid.org/0000-0002-8268-3268","observed_orcids":["https://orcid.org/0000-0002-8268-3268"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mike Laffan","raw_affiliation_strings":["Imperial College Academic Health Sciences Centre, Hammersmith Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College Academic Health Sciences Centre, Hammersmith Hospital, London, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210102902","https://openalex.org/I91136226"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":14.4184,"has_fulltext":false,"cited_by_count":252,"citation_normalized_percentile":{"value":0.99194255,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"160","issue":"1","first_page":"35","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.06379999965429306,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.04450000077486038,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hemorrhage-control","display_name":"hemorrhage control","score":0.8220000267028809},{"id":"https://openalex.org/keywords/antithrombotic-agents","display_name":"antithrombotic agents","score":0.9789999723434448},{"id":"https://openalex.org/keywords/anticoagulation-reversal","display_name":"anticoagulant reversal","score":0.7350000143051147},{"id":"https://openalex.org/keywords/vitamin-k-antagonists","display_name":"vitamin K antagonists","score":0.7770000100135803},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.7210000157356262},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.8180000185966492},{"id":"https://openalex.org/keywords/activated-prothrombin-complex-concentrate","display_name":"activated prothrombin complex concentrate","score":0.8320000171661377},{"id":"https://openalex.org/keywords/recombinant-factor-viia","display_name":"recombinant factor VIIa","score":0.9390000104904175},{"id":"https://openalex.org/keywords/fresh-frozen-plasma","display_name":"fresh frozen plasma","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tranexamic-acid","display_name":"tranexamic acid","score":0.9430000185966492},{"id":"https://openalex.org/keywords/desmopressin","display_name":"desmopressin","score":0.8569999933242798},{"id":"https://openalex.org/keywords/platelet-transfusion","display_name":"platelet transfusion","score":0.9120000004768372},{"id":"https://openalex.org/keywords/emergency-surgery","display_name":"emergency surgery","score":0.7039999961853027},{"id":"https://openalex.org/keywords/invasive-procedures","display_name":"invasive procedures","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.8127588033676147},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.7876538038253784},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7423273921012878},{"id":"https://openalex.org/C2909817843","wikidata":"https://www.wikidata.org/wiki/Q575222","display_name":"Fibrinolytic agent","level":3,"score":0.4856468439102173},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.48463279008865356},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.293499231338501},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09468799829483032}],"mesh":[{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bjh.12107","doi":"https://doi.org/10.1111/bjh.12107","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.12107","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:23116425","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23116425","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire_cris_publications/08943261-121a-41d6-bd01-b789f02a01b6","doi":null,"is_oa":false,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/08943261-121a-41d6-bd01-b789f02a01b6","pdf_url":null,"source":{"id":"https://openalex.org/S7407055359","display_name":"Explore Bristol Research","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Makris, M, Van Veen, J J, Tait, C R, Mumford, A D, Laffan, M 2013, 'Guideline on the management of bleeding in patients on antithrombotic agents', British Journal of Haematology, vol. 160, no. 1, pp. 35-46. https://doi.org/10.1111/bjh.12107","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":105,"referenced_works":["https://openalex.org/W105681134","https://openalex.org/W140642053","https://openalex.org/W1492431817","https://openalex.org/W1501992550","https://openalex.org/W1514693069","https://openalex.org/W1516782956","https://openalex.org/W1542111050","https://openalex.org/W1560217929","https://openalex.org/W1566712571","https://openalex.org/W1604179688","https://openalex.org/W1645143428","https://openalex.org/W1760722428","https://openalex.org/W1823777891","https://openalex.org/W1857260508","https://openalex.org/W1877581810","https://openalex.org/W1888905685","https://openalex.org/W1935339080","https://openalex.org/W1971517546","https://openalex.org/W1971917522","https://openalex.org/W1974753026","https://openalex.org/W1975507736","https://openalex.org/W1976250178","https://openalex.org/W1977188830","https://openalex.org/W1977314095","https://openalex.org/W1980136758","https://openalex.org/W1983585487","https://openalex.org/W1986117726","https://openalex.org/W1989290253","https://openalex.org/W1989848588","https://openalex.org/W1990134290","https://openalex.org/W1991532728","https://openalex.org/W1992298417","https://openalex.org/W1994252458","https://openalex.org/W1994357312","https://openalex.org/W1997007223","https://openalex.org/W2000606571","https://openalex.org/W2002777933","https://openalex.org/W2007326548","https://openalex.org/W2008200932","https://openalex.org/W2013999405","https://openalex.org/W2019630394","https://openalex.org/W2021754784","https://openalex.org/W2021865241","https://openalex.org/W2023394373","https://openalex.org/W2024623688","https://openalex.org/W2032709663","https://openalex.org/W2034368138","https://openalex.org/W2036872916","https://openalex.org/W2041946499","https://openalex.org/W2043113187","https://openalex.org/W2045364354","https://openalex.org/W2045857341","https://openalex.org/W2050122800","https://openalex.org/W2052899600","https://openalex.org/W2053632917","https://openalex.org/W2054567238","https://openalex.org/W2059215195","https://openalex.org/W2063207586","https://openalex.org/W2064722893","https://openalex.org/W2065884275","https://openalex.org/W2066057619","https://openalex.org/W2067835153","https://openalex.org/W2073308951","https://openalex.org/W2073670989","https://openalex.org/W2087368566","https://openalex.org/W2092937726","https://openalex.org/W2093419330","https://openalex.org/W2097854437","https://openalex.org/W2098205472","https://openalex.org/W2099409915","https://openalex.org/W2103247642","https://openalex.org/W2104125790","https://openalex.org/W2105623104","https://openalex.org/W2109556344","https://openalex.org/W2113446992","https://openalex.org/W2113988483","https://openalex.org/W2114610025","https://openalex.org/W2115279806","https://openalex.org/W2116088302","https://openalex.org/W2118420217","https://openalex.org/W2121964226","https://openalex.org/W2123357614","https://openalex.org/W2123622204","https://openalex.org/W2124149640","https://openalex.org/W2127953568","https://openalex.org/W2129089845","https://openalex.org/W2132560377","https://openalex.org/W2135423267","https://openalex.org/W2136489990","https://openalex.org/W2139343852","https://openalex.org/W2150072302","https://openalex.org/W2160840488","https://openalex.org/W2162508946","https://openalex.org/W2170550513","https://openalex.org/W2203036336","https://openalex.org/W2323559086","https://openalex.org/W2355654874","https://openalex.org/W2481569543","https://openalex.org/W2548934243","https://openalex.org/W2575256536","https://openalex.org/W2590742034","https://openalex.org/W2594930958","https://openalex.org/W4238696256","https://openalex.org/W4253074915","https://openalex.org/W4324114342"],"related_works":["https://openalex.org/W7214129253","https://openalex.org/W2057533984","https://openalex.org/W1516782956","https://openalex.org/W2559818544","https://openalex.org/W3031761002","https://openalex.org/W2750249358","https://openalex.org/W2766909401","https://openalex.org/W2138687516","https://openalex.org/W2115152718","https://openalex.org/W7213777390"],"abstract_inverted_index":{"The":[0,13,97,128,170,611,758,812,950,987,1097,1125,1204,1522,1660,1690,1720,1729,1825,2121,2156,3788,3835,4005,4356,4485,4636,4666,4765],"guideline":[1,51,103,129,294,2033],"writing":[2,98],"group":[3,99],"was":[4,105,130,450,1257,1480,1663,1883,2281,2439,2607,2799,2971,3191,3272,3346,3988,4091,4162,4725,4757],"selected":[5],"to":[6,27,32,57,158,176,344,388,501,552,727,739,824,905,980,1013,1022,1101,1164,1485,1534,1773,1875,1885,1888,2163,2296,2369,2376,2441,2458,2466,2481,2533,2609,2667,2753,2778,2840,3064,3080,3200,3247,3274,3330,3348,3623,3699,3943,4054,4063,4094,4134,4148,4239,4432,4472,4509,4645,4737,4819,4827,4846],"be":[7,242,289,403,596,619,632,833,859,869,892,967,981,993,1043,1057,1145,1162,1385,1713,1886,2147,2309,2370,2456,2501,2531,2534,2668,3065,3078,3081,3105,3163,3224,3323,3331,3377,3468,3483,3508,3866,4011],"representative":[8],"of":[9,44,112,119,137,163,172,183,204,299,334,360,436,439,445,480,505,508,547,550,565,600,613,650,702,711,742,763,765,782,788,815,850,855,897,917,926,940,952,990,1015,1030,1099,1115,1119,1127,1129,1168,1175,1261,1280,1312,1325,1332,1337,1350,1353,1372,1375,1399,1475,1494,1520,1598,1606,1613,1623,1734,1749,1752,1763,1865,1878,1943,2005,2016,2089,2107,2112,2123,2125,2143,2151,2237,2253,2264,2270,2278,2326,2341,2372,2403,2424,2475,2492,2507,2564,2605,2613,2633,2688,2784,2862,2883,2908,2956,2968,3017,3035,3044,3056,3088,3127,3196,3214,3301,3307,3314,3318,3338,3364,3390,3407,3424,3431,3436,3439,3454,3460,3513,3522,3538,3556,3563,3574,3589,3599,3607,3653,3760,3764,3773,3776,3808,3811,3838,3862,3894,3909,3985,3993,4007,4071,4080,4116,4122,4145,4174,4184,4187,4203,4205,4248,4261,4272,4319,4329,4379,4398,4416,4426,4458,4540,4549,4553,4585,4614,4642,4649,4668,4680,4700,4823,4843,4885],"UK-based":[10],"medical":[11],"experts.":[12],"MEDLINE":[14],"and":[15,30,41,87,115,144,151,161,213,264,286,313,332,418,465,494,536,539,555,567,576,593,616,646,698,713,725,731,748,755,761,800,817,864,881,1008,1033,1061,1071,1131,1196,1222,1232,1256,1342,1367,1496,1532,1560,1600,1610,1651,1666,1684,1702,1731,1754,1798,1845,1901,1977,2061,2070,2075,2098,2117,2132,2207,2242,2283,2288,2394,2448,2453,2510,2521,2619,2643,2692,2701,2713,2720,2794,2819,2823,2825,2886,2897,2905,2910,2929,2958,2979,2995,3022,3050,3101,3130,3139,3182,3220,3230,3243,3280,3341,3374,3384,3464,3551,3616,3626,3632,3694,3795,3797,3827,3840,3848,3897,3903,4043,4051,4118,4166,4178,4221,4255,4274,4301,4342,4344,4369,4435,4476,4492,4498,4520,4536,4565,4596,4617,4647,4651,4670,4735,4800,4812,4858,4873],"EMBASE":[16],"databases":[17],"were":[18,52,91,767,1135,1226,2027,2730,3020,3245],"searched":[19,93],"systematically":[20,3729],"for":[21,94,123,148,247,434,447,514,572,637,666,700,719,1292,1404,1454,1556,1761,1853,2013,2138,2149,2231,2243,2298,2646,2674,2879,2954,2973,2981,2991,3111,3310,3325,3510,3568,3601,3770,3786,3913,3991,4026,4141,4216,4229,4718,4792],"publications":[22],"in":[23,49,125,228,301,375,392,399,405,455,459,461,469,471,489,491,589,598,621,624,653,804,826,900,1011,1209,1251,1259,1314,1397,1591,1628,1657,1672,1698,1705,1777,1787,1869,1904,1925,1939,1981,1985,2007,2029,2058,2078,2083,2213,2246,2272,2294,2362,2407,2434,2451,2566,2602,2616,2621,2623,2636,2659,2676,2697,2702,2721,2732,2743,2762,2844,2869,2889,2914,2961,2993,2999,3012,3059,3086,3113,3135,3140,3145,3175,3268,3312,3335,3676,3689,3702,3712,3730,3778,3938,3956,4013,4096,4164,4172,4246,4306,4316,4338,4361,4407,4449,4483,4524,4579,4591,4832,4850],"English":[24],"from":[25,878,894,1090,1133,1180,1461,1928,3621,3715,4129,4574,4855],"1966":[26],"June":[28,33],"2011":[29,34],"1980":[31],"respectively,":[35,2293,2913,3635],"using":[36,907,1207,1290,1390,2511,2536,2592,2746,3148,3178],"the":[37,45,50,101,113,120,142,145,181,284,297,304,323,335,338,357,437,506,537,545,548,563,693,703,709,717,743,779,836,846,895,901,908,978,996,1113,1116,1148,1156,1166,1240,1253,1278,1309,1462,1653,1658,1745,1764,1794,1819,1842,1861,1866,1973,1983,2003,2014,2054,2059,2064,2090,2109,2115,2119,2126,2135,2164,2187,2205,2261,2275,2286,2380,2408,2422,2445,2476,2493,2508,2555,2561,2593,2603,2631,2644,2686,2734,2747,2755,2780,2815,2927,2935,2938,2965,2988,3014,3042,3053,3089,3125,3149,3158,3194,3201,3212,3217,3231,3250,3276,3282,3302,3315,3352,3362,3382,3388,3420,3437,3458,3514,3572,3587,3597,3617,3673,3774,3792,3798,3860,3906,3921,3935,3994,4027,4078,4149,4185,4262,4291,4317,4322,4362,4408,4450,4537,4541,4547,4550,4575,4580,4678,4698,4701,4821,4828,4841],"following":[38,694,3193,3655],"strategy:":[39],"Approved":[40],"proprietary":[42],"names":[43],"antithrombotic":[46,186,257,280,308,339,361,390,440,1515,4551],"agents":[47,309,433,571,578,3478,3785,4025,4287,4358,4373],"described":[48,217,1216],"combined":[53],"with":[54,245,261,452,835,872,887,1059,1147,1265,1277,1317,1355,1402,1488,1492,1507,1528,1595,1789,1906,1917,1932,2037,2129,2153,2183,2215,2222,2285,2301,2328,2568,2678,2802,2846,2916,2950,3010,3115,3152,3156,3166,3227,3387,3548,3691,3739,3958,3967,3972,4047,4056,4084,4088,4243,4308,4394,4418,4582,4593,4603,4677,4686,4759,4861],"terms":[55],"relating":[56],"antidote,":[58,3366],"reversal,":[59],"haemorrhage,":[60],"(activated)":[61],"prothrombin":[62,414,676,3278],"complex":[63,415],"concentrate,":[64],"factor":[65,75,410,423,2865,4656,4671,4766],"VIII":[66,424],"inhibitor":[67,425,1650,1813,1948,2789],"bypass":[68,426,1416],"activity":[69,427,831,1118,1143,1374,1510,1516,1711,1980,4529],"(FEIBA),":[70],"Beriplex,":[71],"Octaplex,":[72],"recombinant":[73,1647,4388,4413,4455],"activated":[74,409,419,679,838,2437,2461,2600],"VII":[76,411],"(rFVIIa),":[77],"Novoseven,":[78],"fresh":[79],"frozen":[80,628],"plasma,":[81],"tranexamic":[82],"acid,":[83],"antifibrinolytic,":[84],"platelet":[85,3409,3527,3531,3564,3746,3809,3863,3978,4008,4041],"transfusion,":[86],"desmopressin.":[88],"Identified":[89],"papers":[90],"also":[92,1154,1327,1840,2073,2358,2587,2800,4638],"additional":[95],"references.":[96],"produced":[100],"draft":[102],"which":[104,248,498,875,957,3003,3823,4381,4805],"subsequently":[106],"revised":[107],"by":[108,110,133,684,861,995,1239,1387,1575,1681,1715,1718,1796,1835,2204,2503,2554,2760,2926,2934,3287,3355,3529,3613,3818,3926,4131,4290,4376,4405,4447,4577],"consensus":[109],"members":[111],"Haemostasis":[114],"Thrombosis":[116],"task":[117],"Force":[118],"British":[121,146],"Committee":[122,150],"Standards":[124],"Haematology":[126,149],"(BCSH).":[127],"then":[131,4382],"reviewed":[132,769,1137,1738],"a":[134,483,527,633,648,663,805,883,937,1347,1351,1369,1391,1504,1646,1809,1944,2030,2168,2209,2235,2251,2359,2363,2395,2400,2473,2706,2722,2803,2853,2900,3173,3188,3208,3238,3264,3402,3472,3520,3535,3553,3651,3805,3885,3891,3982,4069,4107,4113,4119,4226,4345,4395,4412,4454,4479,4561,4583],"sounding":[135],"board":[136],"approximately":[138,1122,1173,1376,1693,4771],"50":[139,944],"UK":[140,2060,4363],"haematologists,":[141],"BCSH":[143,2032],"Society":[147],"comments":[152],"incorporated":[153],"where":[154],"appropriate.":[155],"Criteria":[156],"used":[157,226,307,1163,2057,2077,2230],"quote":[159],"levels":[160,1269,2088,2176],"grades":[162],"evidence":[164,561,718,738,2420,2551,2645,3562,3698],"are":[165,225,250,342,364,372,384,429,499,541,706,750,1019,1088,1758,1999,2072,2134,2316,2411,2641,2868,2924,2931,3309,3415,3446,3450,3479,3611,3630,3781,3856,3924,4021,4034,4044,4257,4288,4704,4836,4853,4859],"as":[166,320,322,432,482,526,569,647,662,1573,2137,2318,2515,3040,3095,3485,3487,3854,4060,4225],"outlined":[167],"in:":[168],"http://www.bcshguidelines.com/BCSH_PROCESS/EVIDENCE_LEVELS_AND_GRADES_OF_RECOMMENDATION/43_GRADE.html.":[169],"objective":[171],"this":[173,293,521,584,796,1158,1673,2084,2319,2356,2797,3328,3703,3723],"document":[174],"is":[175,238,259,282,340,510,523,559,644,722,746,784,876,954,958,1346,1364,1450,1503,1525,1540,1552,1645,1652,1669,1676,1687,1692,1722,1769,1808,1815,1828,1832,1849,2053,2160,2189,2201,2229,2343,2357,2367,2405,2463,2552,2665,2672,2821,2838,3062,3109,3491,3579,3637,3686,3696,3767,3884,3898,4106,4127,4214,4241,4336,4387,4402,4411,4444,4453,4469,4488,4494,4543,4555,4560,4571,4589,4713,4817],"guide":[177,740],"healthcare":[178],"professionals":[179],"on":[180,202,303,752,1108,1178,1419,1954,2002,2018,2034,2379,2426,2630,2639,2683,2773,2817,2828,2849,2856,3120,3216,3368,3576,3659,4266,4710,4783],"management":[182,240,298,2015,2423],"patients":[184,302,472,822,1210,1218,1224,1255,1264,1316,1400,1707,1788,1930,2017,2214,2299,2327,2468,2567,2638,2677,2845,2915,3114,3444,3690,3731,3957,4014,4055,4175,4307,4339,4592,4785],"receiving":[185,1230,3732,4176,4340],"drugs":[187,224,319,362,391,1974,2066,2082,3069,3394,3449,4036,4050,4605,4688,4703,4849],"who":[188,193,1233,3445,4015,4786],"experience":[189],"significant":[190,1069,1318,2332,3047],"bleeding":[191,233,300,348,449,604,856,921,1228,1250,1282,1319,1395,1413,1873,1955,1960,2008,2024,2280,2364,2425,2467,2499,2637,2682,2709,2829,2848,2970,3019,3057,3119,3218,3258,3425,3591,3600,3674,3936,4082,4210,4218,4304,4323,4879],"or":[192,197,346,352,602,639,678,842,853,1094,1717,2022,2025,2255,2335,2353,2416,2538,2680,3117,3122,3198,3422,3434,3877,4098,4720],"require":[194],"emergency":[195,376,1220,3511,3771],"surgery":[196,1221,1417,1786,1882,3642],"an":[198,511,923,1356,1940,2525,2622,2742,2857,2892,3144,3334,3365,4061,4506],"invasive":[199],"procedure.":[200],"Guidance":[201],"reversal":[203,253,435,484,635,664,701,906,988,1294,2124,3306,3418,3435,3512,3772,3784,4024],"vitamin":[205,2091,2130,2144,4809],"K":[206,2131,2145,2952],"antagonists":[207,3790,3923,3969,4086],"(VKAs;":[208],"warfarin,":[209,670],"phenprocoumon,":[210,2067],"acenocoumarol":[211,2068,2118],"(sinthrome)":[212,2069],"phenindione":[214,2071],"has":[215,486,585,608,658,971,1368,1421,1625,2208,2542,3534,3552,3725,3890,4112,4222,4348,4566],"been":[216,487,587,609,972,1422,1626,1737,2048,2695,2877,3133,3727,4223,4350],"previously":[218,4862],"(Keeling":[219,2039],"et":[220,267,271,476,517,771,809,947,984,1080,1139,1184,1188,1193,1201,1213,1244,1285,1299,1303,1321,1380,1430,1434,1438,1442,1446,1465,1499,1544,1580,1584,1617,1633,1637,1641,1741,1804,1894,1898,1909,1913,1935,1963,1990,1995,2040,2197,2304,2387,2430,2487,2574,2579,2584,2652,2717,2738,2791,2806,2810,2984,3026,3204,3234,3260,3290,3294,3358,3494,3498,3502,3582,3644,3664,3668,3681,3719,3750,3754,3870,3874,3880,3930,3946,3950,3998,4002,4102,4154,4194,4251,4332,4440,4461,4621,4625,4629,4633,4659,4663,4690,4694,4743,4747,4751,4762,4775,4779,4866,4870],"al,":[221,268,272,477,518,772,810,948,985,1081,1140,1185,1189,1194,1202,1214,1245,1286,1300,1304,1322,1381,1431,1435,1439,1443,1447,1466,1500,1545,1581,1585,1618,1634,1638,1642,1742,1805,1895,1899,1910,1914,1936,1964,1991,1996,2041,2198,2305,2388,2488,2575,2580,2653,2718,2739,2792,2807,2811,2985,3027,3205,3235,3261,3291,3295,3359,3495,3499,3503,3583,3645,3665,3669,3682,3720,3751,3755,3871,3875,3881,3931,3947,3951,3999,4003,4103,4155,4195,4252,4333,4441,4462,4622,4626,4630,4634,4660,4664,4691,4695,4744,4748,4752,4763,4776,4867,4871],"2011).":[222,1287,1643,2042,2812,2986,3028,3296,3360,3504,3919,3932,4876],"Antithrombotic":[223],"increasingly":[227],"patient":[229,336,463,2365,3037,3704],"groups":[230,464,4100],"at":[231,793,1054,1236,1482,1569,1725,2234,2250,2548,2902,3041,3451,4727,4732,4739,4770],"greater":[232,4480,4522],"risk.":[234,4211],"Although":[235,1151,3297,4697],"major":[236,654,2021,2279,2339,2679,2969,3018,3116,4081,4878],"haemorrhage":[237,4682],"infrequent,":[239],"can":[241,857,868,992,999],"difficult":[243,2368],"especially":[244],"antithrombotics":[246,667,697],"there":[249,558,1768,3414,3695],"no":[251,659,1451,1553,1850,1952,2000,2412,3416,3697,3782,4022,4837],"specific":[252,1452,1554,1851,3417,3783,4023,4471],"agents.":[254,325],"Bleeding":[255,934,4600],"during":[256,922,2009,4684],"therapy":[258,4791],"associated":[260,451,3386,4083,4242],"high":[262,2401,2418,3071,3452,4209],"morbidity":[263],"mortality":[265],"(Linkins":[266],"2003;":[269,1301,1896,3666,4631],"Eikelboom":[270],"2006;":[273,4463],"Mannucci":[274],"&":[275,689,1037,1050,1075,1409,1548,2768,3169,3917,4190,4235,4312,4353],"Levi,":[276],"2007).":[277,1937,2770,3171],"Before":[278],"any":[279,4844],"treatment":[281,852,1753,2882,3421,3433,4330,4602,4685],"started,":[283],"risks":[285,538,3016,3383],"benefits":[287,540,3385],"should":[288,1042,1160,2146,2500,3104,3467,3482],"carefully":[290,542,3380,3470],"considered.":[291,610],"In":[292,326,692,1558,2181,2260,2490,2524,2685,2705,2741,2771,2920,2937,2987,3124,3143,3172,3207,3237,3263,3333,3361,3757,4068],"we":[295,4887],"consider":[296],"more":[305,622,2795,3899],"widely":[306,2076],"including":[310,1004,4611],"heparin,":[311],"anti-IIa":[312,1102],"anti-Xa":[314,1100,1149,1373,1388,1509],"inhibitors,":[315],"oral":[316,2035,2173,2864,2893,3541],"VKAs,":[317,557],"anti-platelet":[318,3432,3448,3477,3515,3830,3907,4049],"well":[321],"fibrinolytic":[324,4357,4528,4604,4687,4702,4848],"many":[327,2323,3443],"cases,":[328,2922],"simple":[329,2518],"non-pharmacological":[330],"measures":[331,533,1757,4825],"stabilization":[333],"whist":[337],"eliminated":[341,1817,2203,3925,4128,4289,4572],"sufficient":[343,1760],"treat":[345],"prevent":[347,2482,3962,4038],"(Table":[349,3411],"1).":[350],"Plasmapheresis":[351],"haemofiltration":[353,2539],"may":[354,402,579,595,631,832,891,966,1056,1067,1144,1153,1384,1567,1712,3376,3400,3507,3518,3566,3803,3865,3911,4010,4138,4179,4606],"rapidly":[355,870,1816,2161,4326,4573],"reduce":[356,2086,4639],"plasma":[358,629,780,827,848,1370,1486,1523,1747,1826,2175,2211,2528,2545,2562,2765,3072,3154,3397,3554,3714,3844,3892,4120,4130,4276,4396,4525,4538,4640],"concentration":[359,2352,2374],"that":[363,673,910,1225,1511,1565,1781,1814,2312,2344,2399,2436,2460,2557,2589,3605,3889,4037,4111,4268],"not":[365,385,586,1161,1275,1491,1670,2348,2826,3077,3255,3595,3638,3726,4349,4675],"highly":[366,379],"protein":[367,828,2546,3073],"bound.":[368],"However,":[369,394,442,656,792,1456,1838,1938,2140,3442,3560,3684,3905,4315,4546,4815],"these":[370,2045,2314,2634,2842,3030,3068,3391,4824],"techniques":[371,2635],"often":[373,430,524,723,858,1759],"inaccessible":[374],"settings":[377,599,2660],"outside":[378,2661],"specialized":[380],"units.":[381],"Specific":[382],"antidotes":[383],"always":[386],"available":[387,2074,2595,2642,2673,2836,3110,3303],"reverse":[389,553,3256,4847],"emergencies.":[393],"general":[395,865,1755,3427],"pro-haemostatic":[396,3465],"agents,":[397,3419],"listed":[398],"Table":[400],"2":[401,902,2479],"useful":[404],"some":[406,735,2079,3036],"circumstances.":[407],"Recombinant":[408],"(rFVIIa,":[412],"Novoseven\u00ae),":[413],"concentrates":[416],"(PCC)":[417],"PCC":[420,551,566,575,592,615,643,1329,1978,2133,2691,2804,3131,3199,3242,3271],"[APCC;":[421],"e.g.":[422],"(FEIBA)]":[428],"considered":[431,525,597,1671,2148,3469,3509],"effect":[438,507,705,745,819,989,1765,1868,1953,2111,2128,2354,2378,3308,3405,3438,3516,3775,3831,3908,3996,4552,4709],"drugs.":[441],"off-label":[443],"use":[444,549,564,612,1311,2004,2346,2632,2675,3112,3389],"rFVIIa":[446,481,515,1291,1313,1338,1479,1566,1603,1624,1907,1918,1950,2712,2751,2776,2818,3129,3167,3197,3229,3244,3373,3707],"critical":[448,601],"arterial":[453,3455,3523],"thrombosis":[454,581,606],"5\u00b75%":[456],"vs.":[457,467],"3\u00b72%":[458],"placebo":[460,470,1588,4097],"all":[462,531,1252,2444],"10\u00b78%":[466],"4\u00b71%":[468],">75":[473],"years":[474],"(Levi":[475],"2010).":[478,1915],"Efficacy":[479],"agent":[485,522,636,665,3724],"demonstrated":[488,1604,1627,3650],"vitro,":[490,2698,3136],"animal":[492,756,1181,1941,1986,2703,3141,3210,3369],"studies":[493,1182,1289,1563,3370,3648],"single":[495],"case":[496,729,732,1630],"reports,":[497],"subject":[500],"publication":[502],"bias.":[503],"Reversal":[504],"anti-thrombotics":[509],"unlicensed":[512],"indication":[513],"(Sorour":[516],"2010)":[519],"but":[520,1330,1490,1855,2100,2355,2871,3253,3327,3399,3517,3545,3593,3722,3953,4136,4207],"last":[528],"resort":[529],"when":[530,1478,1537,1767],"other":[532,556,573,640,668,2417,4048,4089,4511,4652],"have":[534,1068,1736,2047,2101,2471,2694,2876,2906,3132,3395,3401,3649,3842,4016,4269],"failed":[535,2752,2777],"documented.":[543],"With":[544,708,1966],"exception":[546,710],"warfarin":[554,638,2019,2038,2052,2302,2982,3011],"little":[560],"supporting":[562],"APCC":[568,577,594,617,1495,1958,1976,2006,2693,2820,3232,3375],"correction":[570,741,1572,1605,1762,1864,2150,3190,3992],"antithrombotics.":[574,3441],"increase":[580,3596],"risk":[582,607,1055,2277,2967,3055,3453,3474,3521,3588,4079,4305,4324],"although":[583,3853,3981],"evaluated":[588],"large-scale":[590],"meta-analyses.":[591],"refractory":[603],"after":[605,936,1270,1414,1517,1784,1880,3379,3489,3540,3941,4219,4327,4534,4601,4789],"rFVIIa,":[614,2690],"will":[618],"discussed":[620],"detail":[623],"subsequent":[625],"sections.":[626],"Fresh":[627],"(FFP)":[630],"suitable":[634],"VKA":[641,2065],"(if":[642],"unavailable)":[645],"source":[649],"clotting":[651,839,2093,4653],"factors":[652,687,1018,2094],"haemorrhage.":[655],"FFP":[657,1497],"proven":[660,4351],"efficacy":[661,1622,3701,4006,4842],"than":[669,960,3901,3990,4474],"even":[671],"those":[672],"cause":[674,1000],"prolonged":[675,963,1607,1724,1770,2210,3277,3403],"(PT)":[677],"partial":[680,1473,1571,1611,4567],"thromboplastin":[681],"(APTT)":[682],"times":[683,1609],"inhibiting":[685],"coagulation":[686,1577,1608,2383,3221,4711],"(Crowther":[688,1049],"Warkentin,":[690,1051],"2009).":[691,1082,1586,2306,3206,4442],"sections,":[695],"individual":[696,720,2858,3577],"options":[699],"anticoagulant":[704,744,1070,1117,2110,2127],"discussed.":[707],"VKAs":[712,2152],"unfractionated":[714],"heparin":[715],"(UFH),":[716],"approaches":[721],"weak":[724],"limited":[726,2628],"small":[728,1629,4830],"series":[730,1631],"reports.":[733],"For":[734,919,2043,3083,4877],"antithrombotics,":[736],"clinical":[737,1621,1732,2414,3031,3060,3266,4076,4838],"absent":[747],"recommendations":[749,2046],"based":[751,1177,2827,3367],"theoretical":[753],"considerations":[754],"studies.":[757],"characteristics,":[759],"monitoring":[760,2350],"mechanisms":[762,4610],"action":[764,1128,3539,4117,4273],"UFH":[766,783,816,830,863,867,898,927,970,1091,1134],"recently":[768,1136,1664,1739,2796,4017],"(Gray":[770,1138],"2008).":[773,811,949,986,1052,1141,1246,1305,1501,1743,1806,1997,3236],"At":[774,1063,2813],"therapeutic":[775,1596,1726],"intravenous":[776],"(IV)":[777],"doses,":[778,795,1065,2292],"half-life":[781,807,849,951,1114,1371,1524,1691,1748,1795,1827,2188,2212,2219,3555,3893,4121,4397,4425,4487,4539,4548,4584],"45\u201390":[785],"min":[786,1048,4491,4533],"because":[787,2361,2540,3406,3571,3814,4144],"rapid":[789,2657,3536,4114,4132,4270],"cellular":[790],"elimination.":[791],"higher":[794,1064,3983],"mechanism":[797,1126],"becomes":[798,2835],"saturated":[799],"renal":[801,1530,1700,1774,1791,2185,2216,2333,2571,2918,3048,4296,4309,4320],"clearance":[802,814,1539,1771,2224,2529],"results":[803,1297,3321],"longer":[806,2154,3878],"(Hirsh":[808,946,983,1243],"pharmacokinetic":[813],"pharmacodynamic":[818],"varies":[820],"between":[821,1105,1340],"due":[823,1772,2375,4826],"differences":[825,1132],"binding.":[829],"monitored":[834,994,1146,1386,1714,1834],"APTT,":[837,1157],"time":[840,1956,1961,2393,2710,3219,3279,3619,3675,3937],"(ACT)":[841],"thromboelastometric":[843],"assays.":[844],"Given":[845,1744,3604],"short":[847,1746,1858,2495,3090,3396,3843,4275],"UFH,":[851,961],"prevention":[854,2245,2888,3423],"achieved":[860],"stopping":[862,1860],"measures.":[866],"reversed":[871,3165,3226],"protamine":[873,913,953,964,991,1023,1066,1208,1235,1271],"sulphate,":[874],"derived":[877,1089,4854],"fish":[879,1034],"sperm":[880],"forms":[882],"stable,":[884],"inactive":[885],"salt":[886],"heparin.":[888],"Protamine":[889,998,1040,1171,1247],"dose":[890,939,2236,2252,2474,3661],"calculated":[893],"quantity":[896],"administered":[899,973,4046],"h":[903,1378,1527,1536,1697,1704,2191,2221,2480,2904,2912,3544,3547,3813,3851,3896,4143,4183,4734,4741,4773,4884],"prior":[904],"assumption":[909],"1":[911,1696,4772,4798],"mg":[912,932,945,2239,2257,2290,2975,3007],"neutralizes":[914],"80\u2013100":[915],"units":[916,942,2664],"UFH.":[918],"example,":[920],"IV":[924],"infusion":[925,3759,4188],"1250":[928],"units/h":[929],"requires":[930,943,3426,3816,3824],"25":[931,1694],"protamine.":[933,1335],"soon":[935,3486],"bolus":[938],"5000":[941],"7":[955,3850],"min,":[956,1695,4429],"shorter":[959],"thus,":[962,4477],"administration":[965,1273,2142,3542,4535,4886],"necessary":[968],"if":[969,2469],"subcutaneously,":[974],"causing":[975,4423],"entry":[976],"into":[977,4505],"circulation":[979,1463,4576],"delayed":[982,3806,4590],"APTT.":[997,1719],"severe":[1001,1699,4167,4244],"allergic":[1002],"reactions":[1003,1010],"anaphylaxis,":[1005],"hypotension,":[1006],"bronchospasm":[1007],"skin":[1009],"up":[1012,1533],"10%":[1014,3606],"patients.":[1016],"Risk":[1017],"previous":[1020],"exposure":[1021,3942],"sulphate":[1024,1041,1272],"(including":[1025],"protamine-containing":[1026],"insulin":[1027],"preparations),":[1028],"rate":[1029],"administration,":[1031,2174],"vasectomy":[1032],"allergy":[1035],"(Porsche":[1036],"Brenner,":[1038],"1999).":[1039,4237,4355,4467],"given":[1044,1856,2464],"slowly":[1045],"over":[1046],">5":[1047],"Patients":[1053],"pre-treated":[1058],"corticosteroids":[1060],"antihistamines.":[1062],"antiplatelet":[1072,4618],"effects":[1073,3213,3573],"(Ammar":[1074],"Fisher,":[1076],"1997;":[1077,1432,1436,4661,4692],"Ni":[1078],"Ainle":[1079],"Low":[1083],"molecular":[1084],"weight":[1085],"heparins":[1086],"(LMWH)":[1087],"through":[1092,1679,3471,4608],"chemical":[1093],"enzymatic":[1095],"depolymerization.":[1096],"ratios":[1098],"activities":[1103],"vary":[1104],"products":[1106,2843],"depending":[1107],"LMWH":[1109,1120,1130,1142,1152,1176,1231,1293],"chain":[1110],"length.":[1111],"However":[1112],"lasts":[1121,2114],"4":[1123,3569],"h.":[1124,2180,3834],"test.":[1150],"prolong":[1155],"test":[1159],"assess":[1165,4820],"extent":[1167],"drug":[1169,1862,2477,2509,3462,3800,4542],"effect.":[1170],"reverses":[1172,3708],"60%":[1174],"data":[1179,1307,2001,2816,3304,4839],"(Bang":[1183],"1991;":[1186],"Lindblad":[1187],"1987;":[1190],"Van":[1191,1993,2428,2582,4464],"Ryn-McKenna":[1192],"1990)":[1195],"healthy":[1197,1592,2774,3269,3677,3939],"human":[1198],"volunteers":[1199,1593,3679,3717,3940],"(Holst":[1200],"1994).":[1203,4156],"largest":[1205],"study":[1206,1471,1590,1779,1942,3147,3337],"(Van":[1211,1283,1988,2715,2736],"Veen":[1212,1284],"2011)":[1215,3876,4872],"three":[1217],"requiring":[1219],"14":[1223],"actively":[1227],"whilst":[1229],"received":[1234,1328,1334,4803],"doses":[1237,1484,1597,2506,3763],"suggested":[1238],"ACCP":[1241],"guidelines":[1242,4864],"prevented":[1248],"excessive":[1249],"surgical":[1254,2232,2519,3099,3590],"effective":[1258,2103,2731,3769,4215],"eight":[1260],"12":[1262],"evaluable":[1263],"active":[1266,2165,3799,3836,4507],"bleeding.":[1267],"Anti-Xa":[1268],"did":[1274,3254],"correlate":[1276,4676],"likelihood":[1279],"persistent":[1281,4146],"Animal":[1288],"show":[1295,3070,3804],"contradictory":[1296],"(Chan":[1298],"Lauritzen":[1302],"Registry":[1306],"indicate":[1308],"successful":[1310],"six":[1315,4072,4419],"(Ingerslev":[1320],"2007),":[1323],"two":[1324,1929,2875],"whom":[1326,1333],"none":[1331],"Doses":[1336],"varied":[1339],"20":[1341,1360,2974,3558,4428,4532,4586],"120":[1343],"\u03bcg/kg.":[1344],"Danaparoid":[1345,1363,1383],"heparinoid":[1348],"consisting":[1349],"mixture":[1352],"glycosaminoglycans":[1354],"anti-Xa/anti-IIa":[1357],"ratio":[1358],">":[1359],"(Hirsh,":[1361],"1992).":[1362,1382],"excreted":[1365,1688,2932],"renally":[1366],"24":[1377,4733],"(Danhof":[1379],"assay":[1389],"danaparoid":[1392,1403,1420,1459],"standard.":[1393],"Major":[1394],"occurred":[1396],"8\u00b71%":[1398],"treated":[1401,1594,1931,2300,3966],"heparin-induced":[1405],"thrombocytopenia":[1406,4158,4168,4230,4245],"(HIT)":[1407],"(Magnani":[1408],"Gallus,":[1410],"2006).":[1411,4753],"Continued":[1412],"cardiopulmonary":[1415],"(CPB)":[1418],"reported":[1423,1884,4163,4782],"despite":[1424],"intensive":[1425,2662],"blood":[1426,1801,1889,1902,1926,2618,3181],"product":[1427],"replacement":[1428],"(Schmahl":[1429,1464],"Westphal":[1433],"Gitlin":[1437],"1998;":[1440,4745],"Fernandes":[1441],"2000;":[1444],"Pamboukian":[1445],"2000).":[1448,4764],"There":[1449,1551,1848,1998,2410,3780,4020,4835],"antidote":[1453,1555,1852,2671,3108],"danaparoid.":[1455],"plasmapheresis":[1457],"removes":[1458],"effectively":[1460,2559],"1997).":[1467,4196,4777],"An":[1468,1776],"ex":[1469,1561,1919,2699,3137,3737,3970],"vivo":[1470,1562,1778,1920,2700,3738,3971],"showed":[1472,1780,2433,2588],"restoration":[1474,1612],"thrombin":[1476,1614,1649,1682,1812,1846,1947,1970,2170,2392,2757,2782,2788,3160,3284,3710],"generation":[1477,1615,2758,2783,3161,3285,3711,4378],"added":[1481],"supra-therapeutic":[1483],"spiked":[1487,2763,3155,3179],"danaparoid,":[1489],"addition":[1493,3195],"(Gatt":[1498,1579],"Fondaparinux":[1502],"synthetic":[1505],"pentasaccharide":[1506],"indirect":[1508],"achieves":[1512],"steady":[1513],"state":[1514],"3\u20134":[1518,3546],"d":[1519,3570,3634,3868,3915,4202],"use.":[1521,3963],"17\u201320":[1526],"normal":[1529,1790,2184,2391,2396,2917,4738],"function":[1531,1792,4374],"72":[1535],"creatinine":[1538,2223],"<30":[1541],"ml/min":[1542],"(Donat":[1543],"2002;":[1546,4749],"Samama":[1547],"Gerotziafas,":[1549],"2003).":[1550,4696],"fondaparinux.":[1557],"vitro":[1559,2435,2624,2744,3146,3176,3336],"suggest":[1564],"enable":[1568],"least":[1570],"determined":[1574],"global":[1576],"assays":[1578],"2008;":[1582],"Desmurs-Clavel":[1583],"A":[1587,2338,2390,2860,4754],"controlled":[1589,3265,4075],"fondaparinux":[1599],"90":[1601],"\u03bcg/kg":[1602],"(Bijsterveld":[1616],"2002).":[1619,1709,4104],"Partial":[1620],"(Dao":[1632],"2005;":[1635,1639],"Huvers":[1636],"Luporsi":[1640],"Bivalirudin":[1644,1675,1710],"peptide":[1648],"only":[1654,1685,2874,3187,3349,4801],"licensed":[1655,2878,4360],"hirudin":[1656],"UK.":[1659],"lepirudin":[1661],"licence":[1662],"withdrawn":[1665,3480,3640],"so":[1667,2872,3298],"it":[1668,2366,2454,2541,2837,3815,4493,4504,4816],"guideline.":[1674],"cleared":[1677,4403,4445,4495],"predominantly":[1678],"proteolysis":[1680],"(80%)":[1683],"20%":[1686,1797],"renally.":[1689],"impairment":[1701,2217,2334,3049,4310],"3\u00b75":[1703],"dialysis-dependent":[1706],"(Chew,":[1708],"ACT":[1716,1844],"PT":[1721],"minimally":[1723],"bivalirudin":[1727,1735],"concentrations.":[1728],"pharmacology":[1730],"applications":[1733],"(Warkentin":[1740,2651],"bivalirudin,":[1750],"cessation":[1751,3430,4204,4328],"haemostatic":[1756,3428],"except":[1766],"impairment.":[1775],"modified":[1782,4414],"ultrafiltration":[1783],"CPB":[1785],"reduced":[1793,1799,1876,1959,2781,3672,4012],"postoperative":[1800],"loss":[1802],"(Koster":[1803],"Argatroban":[1807,1831],"reversible":[1810,3900,4259],"direct":[1811,1946,1969,2169,2516,2787,2863,3096,4562],"via":[1818,4496],"hepatic":[1820,3820,3927],"cytochrome":[1821],"P450":[1822],"3A4/5":[1823],"enzyme.":[1824],"45":[1829],"min.":[1830,3559,4125,4400,4545,4558,4587],"usually":[1833,3639,3768,3961,4045],"APTT":[1836,2397],"ratio.":[1837],"argatroban":[1839,1854,1879,1933,2010],"prolongs":[1841],"PT,":[1843],"time.":[1847],"its":[1857,2345,2351,2373],"half-life,":[1859,2497,3091],"enables":[1863],"anticoagulation":[1867,2036],"most":[1870,3300,3602],"cases.":[1871],"Severe":[1872],"related":[1874],"elimination":[1877],"cardiac":[1881],"unresponsive":[1887],"component":[1890],"treatments":[1891],"alone":[1892],"(Edwards":[1893],"Gasparovic":[1897],"2004)":[1900],"components":[1903],"combination":[1905],"(Malherbe":[1908],"2004;":[1911],"Genzen":[1912],"Treatment":[1916],"restored":[1921,3744,3976],"abnormal":[1922,3709,3745,3977],"thromboelastography":[1923],"parameters":[1924,3252,4712],"samples":[1927,2766,3202],"(Young":[1934],"different":[1945,2102,2381,3174],"(melagatran),":[1949],"had":[1951,2472,4795],"whereas":[1957],"(Elg":[1962],"2001).":[1965,4253,4314],"yet":[1967],"another":[1968,2786],"inhibitor,":[1971],"dabigatran,":[1972,2167,2850],"rVIIa,":[1975],"exhibited":[1979],"correcting":[1982,2733],"coagulopathy":[1984,2735],"models":[1987],"Ryn":[1989,1994,2196,2386,2429,2486,2578,2583,2716,2737],"2010a;":[1992],"treatment.":[2011],"Guidelines":[2012],"experiencing":[2020],"non-major":[2023],"over-anticoagulation":[2026],"included":[2028,2049,4806],"recent":[2031],"completeness,":[2044],"below.":[2050],"Whilst":[2051],"main":[2055],"coumarin":[2056],"North":[2062],"America,":[2063],"countries.":[2080],"All":[2081,3920,4371],"class":[2085],"functional":[2087],"K-dependent":[2092],"(II,":[2095],"VII,":[2096],"IX":[2097],"X)":[2099],"half-lives.":[2104,2155],"Following":[2105,2172,2891],"discontinuation":[2106],"treatment,":[2108],"phenprocoumon":[2113],"longest,":[2116],"shortest.":[2120],"principles":[2122],"same":[2136],"warfarin.":[2139],"further":[2141,2483,2505],"pro-drug":[2157],"dabigatran":[2158,2271,2291,2342,2404,2446,2449,2496,2527,2565,2614,2640,2761],"etexilate":[2159,2447],"hydrolysed":[2162],"form":[2166,2604,4415,4457],"inhibitor.":[2171],"peak":[2177,2901],"within":[2178,2478,3832,4181,4200,4882],"2\u20133":[2179,3761,4728],"individuals":[2182],"function,":[2186],"13":[2190],"(range":[2192],"11\u201322":[2193],"h;":[2194,4281],"van":[2195,2577],"2010b).":[2199,2389,2489,2581],"Dabigatran":[2200],"80%":[2202],"kidneys":[2206,4292],"(plasma":[2218],"22\u201335":[2220],"<":[2225,4797],"30":[2226,4124],"ml/min).":[2227],"It":[2228,2307,4401,4443,4515,4570],"thromboprophylaxis":[2233,2880],"150\u2013220":[2238],"once":[2240,2976],"daily":[2241,2977,3009],"stroke":[2244,2887,3625,4719],"atrial":[2247,2273],"fibrillation":[2248,2274],"(AF)":[2249],"110":[2254,2287],"150":[2256,2289],"twice":[2258,3008],"daily.":[2259],"Randomized":[2262],"Evaluation":[2263],"Long-Term":[2265],"Anticoagulation":[2266],"Therapy":[2267],"(RE-LY)":[2268],"trial":[2269,2321,3267],"annual":[2276,2966,3015],"2\u00b771%":[2282],"3\u00b711%":[2284],"comparison":[2295],"3\u00b736%":[2297],"(Connolly":[2303],"must":[2308],"appreciated,":[2310],"however,":[2311],"both":[2313,2895,2921,3228,3241],"figures":[2315],"conservative":[2317],"pivotal":[2320,4073],"excluded":[2322],"real-life":[2324],"situations":[2325],"extreme":[2329,3043],"body":[2330,3045],"weights,":[2331],"multiple":[2336,3051],"co-morbidities.":[2337],"advantage":[2340],"does":[2347,3594,4674],"involve":[2349],"disadvantage":[2360],"sure":[2371],"variable":[2377],"standard":[2382,2512],"tests":[2384,3222],"(van":[2385,2485],"imply":[2398],"level":[2402,2563],"unlikely":[2406],"patient.":[2409],"published":[2413,4863],"trials":[2415,3032],"quality":[2419],"addressing":[2421],"dabigatran.":[2427,2684],"al":[2431,2585,4780],"(2009)":[2432],"charcoal":[2438,2462,2590],"able":[2440,2608,3246,3273,3347],"bind":[2442],"virtually":[2443],"suspended":[2450,2615],"water,":[2452],"would":[2455,2530,3076,3322],"reasonable":[2457,2839],"recommend":[2459],"orally":[2465],"they":[2470,3075,3481,3855],"absorption":[2484],"view":[2491,3087,3313],"relatively":[2494,2543,3687,4706],"minor":[2498,3084,3098],"managed":[2502],"withholding":[2504],"measures,":[2513,3093,3429],"such":[2514,3039,3094],"pressure,":[2517,3097],"intervention":[2520,3100,4066],"fluid":[2522,3102],"replacement.":[2523],"emergency,":[2526],"expected":[2532,3079,3324],"accelerated":[2535],"haemodialysis":[2537,2558],"low":[2544,3660,4731],"binding":[2547,3074,4133,4147,4264],"35%.":[2549],"Supportive":[2550],"provided":[2553],"fact":[2556],"reduces":[2560],"end":[2569],"stage":[2570],"disease":[2572,3693,3960,4595],"(Stangier":[2573],"2010;":[2576],"(2010c)":[2586],"haemoperfusion":[2591],"commercially":[2594],"Gambro":[2596],"Adsorba":[2597],"Cartridge":[2598],"(containing":[2599],"carbon":[2601],"charcoal)":[2606],"remove":[2610],"c.":[2611,3557,3849,4123,4279,4283,4294,4299,4427,4489],"85%":[2612],"bovine":[2617],"circulating":[2620],"system.":[2625],"Only":[2626],"very":[2627,4829],"reports":[2629],"their":[2647,2656,4708],"support":[2648,3700],"remains":[2649,3329],"preliminary":[2650,2822],"2012).":[2654,3262,3584,3756,3882,4004],"Furthermore,":[2655],"deployment":[2658],"care":[2663],"likely":[2666,3063],"challenging.":[2669],"No":[2670,3107],"life-threatening":[2681,2847,3118],"absence":[2687,3126,3363,4318],"this,":[2689,3128],"investigated":[2696,3134],"models.":[2704,3142]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1998407948","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":22},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":24},{"year":2017,"cited_by_count":29},{"year":2016,"cited_by_count":31},{"year":2015,"cited_by_count":36},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
